Prognostic value of various subtypes of extracellular DNA in ovarian cancer patients
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1757-2215
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Prognostic value of various subtypes of extracellular DNA in ovarian cancer patients ; volume:11 ; number:1 ; day:22 ; month:9 ; year:2018 ; pages:1-7 ; date:12.2018
Journal of ovarian research ; 11, Heft 1 (22.9.2018), 1-7, 12.2018
- Urheber
-
Kalavska, Katarina
- Beteiligte Personen und Organisationen
-
Minarik, Tomas
Vlkova, Barbora
Manasova, Denisa
Kubickova, Michaela
Jurik, Andrej
Mardiak, Jozef
Sufliarsky, Jozef
Celec, Peter
Mego, Michal
SpringerLink (Online service)
- DOI
-
10.1186/s13048-018-0459-z
- URN
-
urn:nbn:de:101:1-2018110620590851711939
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kalavska, Katarina
- Minarik, Tomas
- Vlkova, Barbora
- Manasova, Denisa
- Kubickova, Michaela
- Jurik, Andrej
- Mardiak, Jozef
- Sufliarsky, Jozef
- Celec, Peter
- Mego, Michal
- SpringerLink (Online service)
Ähnliche Objekte (12)
Creation of a machine learning-based prognostic prediction model for various subtypes of laryngeal cancer
Expression and promotor hypermethylation of miR-34a in the various histological subtypes of ovarian cancer
Key factors behind various specific phobia subtypes
THR alpha and its subtypes alpha1 and alpha2 are prognostic markers for survival of ovarian cancer patients
Identification of three subtypes of ovarian cancer and construction of prognostic models based on immune-related genes
Cyclophosphamide in Ovarian Cancer Subtypes: Time for a Comeback
Reclassifying ovarian cancer: origins, subtypes and resistance to therapy
Serum N-glycan profiles differ for various breast cancer subtypes
Prognostic impact of breast cancer subtypes in elderly patients
Glycoconjugates as prognostic markers in ovarian cancer
Glycoconjugates as prognostic markers in ovarian cancer
Revealing platelet-related subtypes and prognostic signature in pancreatic adenocarcinoma
Creation of a machine learning-based prognostic prediction model for various subtypes of laryngeal cancer
Expression and promotor hypermethylation of miR-34a in the various histological subtypes of ovarian cancer
Key factors behind various specific phobia subtypes
THR alpha and its subtypes alpha1 and alpha2 are prognostic markers for survival of ovarian cancer patients
Identification of three subtypes of ovarian cancer and construction of prognostic models based on immune-related genes
Cyclophosphamide in Ovarian Cancer Subtypes: Time for a Comeback
Reclassifying ovarian cancer: origins, subtypes and resistance to therapy
Serum N-glycan profiles differ for various breast cancer subtypes
Prognostic impact of breast cancer subtypes in elderly patients
Glycoconjugates as prognostic markers in ovarian cancer
Glycoconjugates as prognostic markers in ovarian cancer
Revealing platelet-related subtypes and prognostic signature in pancreatic adenocarcinoma
Creation of a machine learning-based prognostic prediction model for various subtypes of laryngeal cancer
Expression and promotor hypermethylation of miR-34a in the various histological subtypes of ovarian cancer
Key factors behind various specific phobia subtypes
THR alpha and its subtypes alpha1 and alpha2 are prognostic markers for survival of ovarian cancer patients
Identification of three subtypes of ovarian cancer and construction of prognostic models based on immune-related genes
Cyclophosphamide in Ovarian Cancer Subtypes: Time for a Comeback
Reclassifying ovarian cancer: origins, subtypes and resistance to therapy
Serum N-glycan profiles differ for various breast cancer subtypes
Prognostic impact of breast cancer subtypes in elderly patients
Glycoconjugates as prognostic markers in ovarian cancer
Glycoconjugates as prognostic markers in ovarian cancer